CHICAGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) today announced that Dirk Van de Put, Chief Executive Officer and Luca Zaramella, Chief Financial Officer, will participate in a fireside chat session at the Barclays …
TARRYTOWN, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announces the following September 2024 investor events: Investor Conference Presentations • Morgan Stanley 22nd Annual Global Healthcare Conference at 11:30 …
SANTA ANA, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), today announced that members of its management team will attend the following investor conferences: Needham Virtual Industrial Technology, Robotics, and Clean Tech …
Reported dose-dependent antitumor clinical activity in patients with relapsed/refractory triple-negative breast cancer from the Phase 1 trial of LYL797, a ROR1-targeted Chimeric Antigen Receptor (CAR) T‑cell product candidate enhanced with proprietary anti …
Margin Growth with Gross Profit and Gross Margin Reaching $32.6 Million and 50.4%, Respectively Net Loss of $1.9 Million, Compared to $14.0 Million in Q2 2023 Grew Adjusted EBITDA and Adjusted EBITDA Margin to $14.5 Million and 22.4%, Respectively …
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis technology in their …
SOLANA BEACH, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its …
SUNNYVALE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2024. “Our solid …
This news release constitutes a “designated news release” for the purposes of Marimaca Copper’s prospectus supplement dated May 22, 2024 to its (final) short form base shelf prospectus dated September 12, 2023. VANCOUVER, British Columbia, Aug. 07, 2024 ( …
Delivers sales growth of 5%; OpSec integration on track Narrows range of full year Adjusted EPS guidance to $4.20 to $4.35 WALTHAM, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a …
CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced that management will present or host one-on-one investor meetings at the following investor conferences: Oppenheimer …
LOS ANGELES, Aug. 07, 2024 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (NYSE: MAX), today announced that Co-Founder and CEO Steve Yi will participate in a fireside chat at Canaccord Genuity's 44th Annual Growth Conference in Boston, MA on Tuesday, August 13th …
Acquisition accelerates expansion of ABL Wealth with a diverse suite of products Deal will add up to $600 million in AUM to Abacus ORLANDO, Fla., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering …
CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and second quarter 2024 financial …
MINNEAPOLIS, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced financial results for its second quarter ended June 30, 2024, through an earnings release available on the company’s …
BOCA RATON, Fla., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced financial results for the quarter ended June 30, 2024. “We are pleased to deliver a very strong …
Data from INVOKE-2 Phase 2 clinical trial of AL002 in individuals with early Alzheimer’s disease (AD) on track for Q4 2024 Patient baseline characteristics data for the INVOKE-2 trial confirm the intended study population for testing the effects of AL002 …
SAN CLEMENTE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2024. …
Quarterly revenue of $15.0 million, up 19% year-over-year at the high end of guidance Quarterly bookings of $19.5 million, up 36% year-over-year exceeding guidance SANTA CLARA, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “ …
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second …
07 days 11:48:56
